Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts
Expert Outlook: Fate Therapeutics Through The Eyes Of 9 Analysts
九位分析师眼中的fate therapeutics专家展望
Across the recent three months, 9 analysts have shared their insights on Fate Therapeutics (NASDAQ:FATE), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月中，有9位分析师分享了他们对Fate Therapeutics（纳斯达克股票代码：FATE）的见解，从看好到看淡都有。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他们最近的评级，展示了过去30天内的情绪演变并与之前的几个月进行了比较。
Analysts have set 12-month price targets for Fate Therapeutics, revealing an average target of $6.11, a high estimate of $9.00, and a low estimate of $4.00. This current average has decreased by 6.0% from the previous average price target of $6.50.
分析师为Fate Therapeutics设定了为期12个月的目标股价，揭示了平均目标为6.11美元，最高预估为9.00美元，最低预估为4.00美元。当前平均目标股价比上一平均价格目标下降了6.0%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
In examining recent analyst actions, we gain insights...
通过检查最近的分...
登录免费看全文
登录/注册